Table 1 Clinicopathologic features in the cohort of 180 patients enrolled in this study
Variables | Ā |
|---|---|
Gender (male/female) | 96/84 |
Age | 68.9āĀ±ā0.7 |
BMI | 22.0āĀ±ā0.2 |
ASA-PS | Ā |
Ā 1 | 40 (22.2%) |
āĀ ā„ā2 | 140 (77.8%) |
Histology: well-differentiated | 72 (40%) |
Mean CA19-9 (U/mL) | 1065āĀ±ā319 |
Median CA 19ā9 (U/mL) | 148 |
Tumor size (cm) | 3.34āĀ±ā0.11 |
pT(UICC) | Ā |
Ā 1 | 5 (2.8%) |
Ā 2 | 5 (2.8%) |
Ā 3 | 165 (91.7%) |
Ā 4 | 5 (2.8%) |
pN(UICC) | Ā |
Ā 0 | 57 (31.7%) |
Ā 1 | 78 (43.3%) |
Ā 2 | 45 (25.0%) |
pStage(UICC) | Ā |
Ā IA | 5 (2.8%) |
Ā IB | 3 (1.7%) |
Ā IIA | 50 (27.8%) |
Ā IIB | 77 (42.8%) |
Ā III | 45 (25.0%) |
R0 | 145 (80.6%) |
Surgery | Ā |
Ā PD | 122 |
Ā DP | 58 |
Neoadjuvant chemotherapy | 28 (15.6%) |
Postoperative complications | 83 (46.1%) |